QUINAZOLINAS PARA LA INHIBICIÓN DE PDK1

Nuevos compuestos de quinazolina que son inhibidores de PDK1. Composiciones farmacéuticas que incluyen dichos compuestos y métodos para tratar enfermedades proliferativas, tales como cánceres, con los compuestos o composiciones. The invention provides quinazoline compounds that are inhibitors of PDK...

Full description

Saved in:
Bibliographic Details
Main Authors SHU I WEI, WANG XIAOJING, M, WARNE ROBERT, L, MURRAY JEREMY, M, BASHAM STEVEN, E, JANSEN JOHANNA M, RICO ALICE, NG SIMON, LIN XIAODONG, AMIRI PAYMAN, ZHOU YASHEEN, JAIN RAMA, AIKAWA MINA E, RAMURTHY SAVITHRI, SUBRAMANIAN SHARADHA, PFISTER KEITH
Format Patent
LanguageSpanish
Published 30.12.2008
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Nuevos compuestos de quinazolina que son inhibidores de PDK1. Composiciones farmacéuticas que incluyen dichos compuestos y métodos para tratar enfermedades proliferativas, tales como cánceres, con los compuestos o composiciones. The invention provides quinazoline compounds that are inhibitors of PDK1. Also provided are pharmaceutical compositions including the compounds, and methods of treating proliferative diseases, such as cancers, with the compounds or compositions.
AbstractList Nuevos compuestos de quinazolina que son inhibidores de PDK1. Composiciones farmacéuticas que incluyen dichos compuestos y métodos para tratar enfermedades proliferativas, tales como cánceres, con los compuestos o composiciones. The invention provides quinazoline compounds that are inhibitors of PDK1. Also provided are pharmaceutical compositions including the compounds, and methods of treating proliferative diseases, such as cancers, with the compounds or compositions.
Author RAMURTHY SAVITHRI
SHU I WEI
LIN XIAODONG
PFISTER KEITH
NG SIMON
WARNE ROBERT, L
BASHAM STEVEN, E
ZHOU YASHEEN
RICO ALICE
JANSEN JOHANNA M
JAIN RAMA
AIKAWA MINA E
SUBRAMANIAN SHARADHA
WANG XIAOJING, M
MURRAY JEREMY, M
AMIRI PAYMAN
Author_xml – fullname: SHU I WEI
– fullname: WANG XIAOJING, M
– fullname: WARNE ROBERT, L
– fullname: MURRAY JEREMY, M
– fullname: BASHAM STEVEN, E
– fullname: JANSEN JOHANNA M
– fullname: RICO ALICE
– fullname: NG SIMON
– fullname: LIN XIAODONG
– fullname: AMIRI PAYMAN
– fullname: ZHOU YASHEEN
– fullname: JAIN RAMA
– fullname: AIKAWA MINA E
– fullname: RAMURTHY SAVITHRI
– fullname: SUBRAMANIAN SHARADHA
– fullname: PFISTER KEITH
BookMark eNrjYmDJy89L5WTQCAz19HOM8vcBksEKAY5Bjgo-jgqefh6eTp7Onocn-ym4uCoEuHgb8jCwpiXmFKfyQmluBgU31xBnD93Ugvz41OKCxOTUvNSSeFfn4AADCwsLI2NHYyKUAADfpSZE
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID ECSP088823A
GroupedDBID EVB
ID FETCH-epo_espacenet_ECSP088823A3
IEDL.DBID EVB
IngestDate Fri Jul 19 15:09:25 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Spanish
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_ECSP088823A3
Notes Application Number: EC2008SP08823
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20081230&DB=EPODOC&CC=EC&NR=SP088823A
ParticipantIDs epo_espacenet_ECSP088823A
PublicationCentury 2000
PublicationDate 20081230
PublicationDateYYYYMMDD 2008-12-30
PublicationDate_xml – month: 12
  year: 2008
  text: 20081230
  day: 30
PublicationDecade 2000
PublicationYear 2008
RelatedCompanies NOVARTIS A.G
RelatedCompanies_xml – name: NOVARTIS A.G
Score 2.6003156
Snippet Nuevos compuestos de quinazolina que son inhibidores de PDK1. Composiciones farmacéuticas que incluyen dichos compuestos y métodos para tratar enfermedades...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Title QUINAZOLINAS PARA LA INHIBICIÓN DE PDK1
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20081230&DB=EPODOC&locale=&CC=EC&NR=SP088823A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSU41TjOxNDDRNbJIttA1STIGloMmwMIwJc0oMc0EWMEngq9v8_Uz8wg18YowjWBiyITthQGfE1oOPhwRmKOSgfm9BFxeFyAGsVzAayuL9ZMygUL59m4hti5qsN4xsLoyNlBzcbJ1DfB38XdWc3a2dXVW8wuyDQ4AZicLI2NHZgZWUCsadMy-a5gTaFNKAXKN4ibIwBYANCyvRIiBKbVYmIHTGXbxmjADhy90vhvIhGa9YhEGjcBQTz_HKH8fIBmsEOAY5Kjg46jg6efh6eTp7Hl4sp-Ci6tCgIu3oSiDgptriLOHLtDKeLj34l2d4Y4zFmNgAfb6UyUYFBINLMxTgH0pc2MzCxMT49REs5TkVGDfI9nC3NwwJSlJkkESpzFSeOSkGbjASx5AZxUayDCwlBSVpsoC69WSJDlwiAAAG1d4zQ
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSU41TjOxNDDRNbJIttA1STIGloMmwMIwJc0oMc0EWMEngq9v8_Uz8wg18YowjWBiyITthQGfE1oOPhwRmKOSgfm9BFxeFyAGsVzAayuL9ZMygUL59m4hti5qsN4xsLoyNlBzcbJ1DfB38XdWc3a2dXVW8wuyDQ4AZicLI2NHZgZWc9DhvKCWU5gTaFNKAXKN4ibIwBYANCyvRIiBKbVYmIHTGXbxmjADhy90vhvIhGa9YhEGjcBQTz_HKH8fIBmsEOAY5Kjg46jg6efh6eTp7Hl4sp-Ci6tCgIu3oSiDgptriLOHLtDKeLj34l2d4Y4zFmNgAfb6UyUYFBINLMxTgH0pc2MzCxMT49REs5TkVGDfI9nC3NwwJSlJkkESpzFSeOTkGTg9Qnx94oGu9ZZm4AIvfwCdW2ggw8BSUlSaKgusY0uS5MChAwDpiXu6
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=QUINAZOLINAS+PARA+LA+INHIBICI%C3%93N+DE+PDK1&rft.inventor=SHU+I+WEI&rft.inventor=WANG+XIAOJING%2C+M&rft.inventor=WARNE+ROBERT%2C+L&rft.inventor=MURRAY+JEREMY%2C+M&rft.inventor=BASHAM+STEVEN%2C+E&rft.inventor=JANSEN+JOHANNA+M&rft.inventor=RICO+ALICE&rft.inventor=NG+SIMON&rft.inventor=LIN+XIAODONG&rft.inventor=AMIRI+PAYMAN&rft.inventor=ZHOU+YASHEEN&rft.inventor=JAIN+RAMA&rft.inventor=AIKAWA+MINA+E&rft.inventor=RAMURTHY+SAVITHRI&rft.inventor=SUBRAMANIAN+SHARADHA&rft.inventor=PFISTER+KEITH&rft.date=2008-12-30&rft.externalDBID=A&rft.externalDocID=ECSP088823A